Notice2025-23545

David Halvorson, M.D.; Decision and Order

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 22, 2025

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 243 (Monday, December 22, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 243 (Monday, December 22, 2025)]
[Notices]
[Pages 59869-59871]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-23545]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


David Halvorson, M.D.; Decision and Order

    On September 5, 2025, the Drug Enforcement Administration (DEA or 
Government) issued an Order to Show Cause (OSC) to David Halvorson, 
M.D., of Alabaster, Alabama (Registrant). Request for Final Agency 
Action (RFAA), Exhibit (RFAAX) 1, at 1, 4. The OSC proposed the 
revocation of Registrant's Certificate of Registration, No. BH3453278, 
alleging that Registrant's registration should be revoked because 
Registrant is ``currently without authority to prescribe, administer, 
dispense, or otherwise handle controlled substances in the State of 
Alabama, the state in which [he is] registered with DEA.'' Id. at 2 
(citing 21 U.S.C. 824(a)(3)).\1\
---------------------------------------------------------------------------

    \1\ According to the OSC and Agency records, Registrant's 
registration expired on October 31, 2025. RFAAX 1, at 1. The fact 
that a registrant allows his registration to expire during the 
pendency of an administrative enforcement proceeding does not impact 
the Agency's jurisdiction or prerogative under the Controlled 
Substances Act (CSA) to adjudicate the OSC to finality. Jeffrey D. 
Olsen, M.D., 84 FR 68474, 68476-79 (2019).

---------------------------------------------------------------------------

[[Page 59870]]

    The OSC notified Registrant of his right to file a written request 
for hearing, and that if he failed to file such a request, he would be 
deemed to have waived his right to a hearing and be in default. Id. 
(citing 21 CFR 1301.43). Here, Registrant did not request a hearing, 
and the Agency finds him to be in default. RFAA, at 3.\2\ ``A default, 
unless excused, shall be deemed to constitute a waiver of the 
registrant's/applicant's right to a hearing and an admission of the 
factual allegations of the [OSC].'' 21 CFR 1301.43(e).
---------------------------------------------------------------------------

    \2\ Based on the Government's submissions in its RFAA dated 
October 22, 2025, the Agency finds that service of the OSC on 
Registrant was adequate. The included declaration from a DEA 
Diversion Investigator (DI) indicates that on September 8, 2025, DEA 
employees attempted to personally serve Registrant at his registered 
address, but the address, a business location, appeared to be closed 
and/or abandoned. RFAAX 2, at 1. On the same day, other DEA 
employees attempted to serve Registrant at his residential address, 
where the DEA employees were informed that Registrant lived there 
but was not home. Id. at 1-2. On September 9, 2025, the DI mailed a 
copy of the OSC to Registrant's residential address and received 
proof of delivery, with the delivery signed for by Registrant on 
September 10, 2025. Id. at 2; see also id. at 3. Here, the Agency 
finds that the OSC was successfully served on Registrant by mail and 
that the DI's efforts to serve Registrant by other means were `` 
`reasonably calculated, under all the circumstances, to apprise 
[Registrant] of the pendency of the action.' '' Jones v. Flowers, 
547 U.S. 220, 226 (2006) (quoting Mullane v. Central Hanover Bank & 
Trust Co., 339 U.S. 306, 314 (1950)).
---------------------------------------------------------------------------

    Further, ``[i]n the event that a registrant . . . is deemed to be 
in default . . . DEA may then file a request for final agency action 
with the Administrator, along with a record to support its request. In 
such circumstances, the Administrator may enter a default final order 
pursuant to [21 CFR] 1316.67.'' Id. 1301.43(f)(1). Here, the Government 
has requested final agency action based on Registrant's default 
pursuant to 21 CFR 1301.43(c), (f), 1301.46. RFAA, at 1; see also 21 
CFR 1316.67.

Findings of Fact

    The Agency finds that, in light of Registrant's default, the 
factual allegations in the OSC are deemed admitted. According to the 
OSC, on or about June 6, 2025, the Medical Licensure Commission of 
Alabama revoked Registrant's Alabama medical license. RFAAX 1, at 2. 
According to Alabama online records, of which the Agency takes official 
notice,\3\ Registrant's Alabama medical license remains revoked. 
Alabama Board of Medical Examiners and Medical Licensure Commission 
License Lookup, <a href="https://dashboard.albme.gov/Verification/search.aspx">https://dashboard.albme.gov/Verification/search.aspx</a> 
(last visited date of signature of this Order). Accordingly, the Agency 
finds that Registrant is not licensed to practice medicine in Alabama, 
the state in which he is registered with DEA.\4\
---------------------------------------------------------------------------

    \3\ Under the Administrative Procedure Act, an agency ``may take 
official notice of facts at any stage in a proceeding--even in the 
final decision.'' United States Department of Justice, Attorney 
General's Manual on the Administrative Procedure Act 80 (1947) (Wm. 
W. Gaunt & Sons, Inc., Reprint 1979).
    \4\ Pursuant to 5 U.S.C. 556(e), ``[w]hen an agency decision 
rests on official notice of a material fact not appearing in the 
evidence in the record, a party is entitled, on timely request, to 
an opportunity to show the contrary.'' The material fact here is 
that Registrant, as of the date of this decision, is not licensed to 
practice medicine in Alabama. Accordingly, Registrant may dispute 
the Agency's finding by filing a properly supported motion for 
reconsideration of findings of fact within fifteen calendar days of 
the date of this Order. Any such motion and response shall be filed 
and served by email to the other party and to the DEA Office of the 
Administrator, Drug Enforcement Administration at 
<a href="/cdn-cgi/l/email-protection#aacecfcb84cbcecec584cbdedec5d8c4cfd3d9eacecfcb84cdc5dc"><span class="__cf_email__" data-cfemail="8befeeeaa5eaefefe4a5eaffffe4f9e5eef2f8cbefeeeaa5ece4fd">[email&#160;protected]</span></a>.
---------------------------------------------------------------------------

Discussion

    Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized 
to suspend or revoke a registration issued under 21 U.S.C. 823 ``upon a 
finding that the registrant . . . has had his State license or 
registration suspended . . . [or] revoked . . . by competent State 
authority and is no longer authorized by State law to engage in the . . 
. dispensing of controlled substances.'' With respect to a 
practitioner, DEA has also long held that the possession of authority 
to dispense controlled substances under the laws of the state in which 
a practitioner engages in professional practice is a fundamental 
condition for obtaining and maintaining a practitioner's registration. 
Gonzales v. Oregon, 546 U.S. 243, 270 (2006) (``The Attorney General 
can register a physician to dispense controlled substances `if the 
applicant is authorized to dispense . . . controlled substances under 
the laws of the State in which he practices.' . . . The very definition 
of a `practitioner' eligible to prescribe includes physicians 
`licensed, registered, or otherwise permitted, by the United States or 
the jurisdiction in which he practices' to dispense controlled 
substances. 802(21).''). The Agency has applied these principles 
consistently. See, e.g., James L. Hooper, M.D., 76 FR 71371, 71372 
(2011), pet. for rev. denied, 481 F. App'x 826 (4th Cir. 2012); 
Frederick Marsh Blanton, M.D., 43 FR 27616, 27617 (1978).\5\
---------------------------------------------------------------------------

    \5\ This rule derives from the text of two provisions of the 
CSA. First, Congress defined the term ``practitioner'' to mean ``a 
physician . . . or other person licensed, registered, or otherwise 
permitted, by . . . the jurisdiction in which he practices . . . , 
to distribute, dispense, . . . [or] administer . . . a controlled 
substance in the course of professional practice.'' 21 U.S.C. 
802(21). Second, in setting the requirements for obtaining a 
practitioner's registration, Congress directed that ``[t]he Attorney 
General shall register practitioners . . . if the applicant is 
authorized to dispense . . . controlled substances under the laws of 
the State in which he practices.'' 21 U.S.C. 823(g)(1). Because 
Congress has clearly mandated that a practitioner possess state 
authority in order to be deemed a practitioner under the CSA, DEA 
has held repeatedly that revocation of a practitioner's registration 
is the appropriate sanction whenever he is no longer authorized to 
dispense controlled substances under the laws of the state in which 
he practices. See, e.g., James L. Hooper, M.D., 76 FR at 71371-72; 
Sheran Arden Yeates, M.D., 71 FR 39130, 39131 (2006); Dominick A. 
Ricci, M.D., 58 FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR 
11919, 11920 (1988); Frederick Marsh Blanton, M.D., 43 FR at 27617.
---------------------------------------------------------------------------

    According to Alabama statute, ``dispense'' means ``[t]o deliver a 
controlled substance to an ultimate user or research subject by or 
pursuant to the lawful order of a practitioner, including the 
prescribing, administering, packaging, labeling, or compounding 
necessary to prepare the substance for that delivery.'' Ala. Code 20-2-
2(7) (2025). Further, a ``practitioner'' includes a ``physician . . . 
or other person licensed, registered, or otherwise permitted to 
distribute, dispense, conduct research with respect to, or to 
administer a controlled substance in the course of professional 
practice or research in [the] state.'' Id. at Sec.  20-2-2(20)(a).
    Here, the undisputed evidence in the record is that Registrant 
lacks authority to practice medicine in Alabama. As discussed above, an 
individual must be a licensed practitioner to dispense a controlled 
substance in Alabama. Thus, because Registrant lacks authority to 
practice medicine in Alabama and, therefore, is not authorized to 
handle controlled substances in Alabama, Registrant is not eligible to 
maintain a DEA registration. Accordingly, the Agency will order that 
Registrant's DEA registration be revoked.

Order

    Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. 
BH3453278 issued to David Halvorson, M.D. Further, pursuant to 28 CFR 
0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I 
hereby deny any pending applications of David Halvorson, M.D., to renew 
or modify this registration, as well as any other pending application 
of David Halvorson, M.D., for additional registration in Alabama. This 
Order is effective January 21, 2026.

[[Page 59871]]

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
December 15, 2025, by Administrator Terrance C. Cole. That document 
with the original signature and date is maintained by DEA. For 
administrative purposes only, and in compliance with requirements of 
the Office of the Federal Register, the undersigned DEA Federal 
Register Liaison Officer has been authorized to sign and submit the 
document in electronic format for publication, as an official document 
of DEA. This administrative process in no way alters the legal effect 
of this document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2025-23545 Filed 12-19-25; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on December 22, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.